Italia markets closed

BMY Jan 2025 45.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
3,3000+0,1000 (+3,12%)
Alla chiusura: 03:54PM EDT
Schermo intero
Chiusura precedente3,2000
Aperto3,4500
Denaro3,2500
Lettera3,6500
Prezzo d'esercizio45,00
Scadenza2025-01-17
Min-Max giorno3,2000 - 3,5000
Contratto - Min-MaxN/D
Volume106
Open Interest2,26k
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri